BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34427583)

  • 1. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
    Bourbon E; Maucort-Boulch D; Fontaine J; Mauduit C; Sesques P; Safar V; Ferrant E; Golfier C; Ghergus D; Karlin L; Lazareth A; Bouafia F; Pica GM; Orsini-Piocelle F; Rocher C; Gros FX; Parrens M; Dony A; Rossi C; Ghesquières H; Bachy E; Traverse-Glehen A; Sarkozy C
    Blood Adv; 2021 Aug; 5(16):3227-3239. PubMed ID: 34427583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.
    Witte HM; Merz H; Biersack H; Bernard V; Riecke A; Gebauer J; Lehnert H; von Bubnoff N; Feller AC; Gebauer N
    Br J Haematol; 2020 Apr; 189(2):257-268. PubMed ID: 31958882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV
    Xing TY; Duan ZW; Wang WT; Du KX; Shen HR; Yin H; Wu JZ; Li Y; Wang L; Li JY; Liang JH; Xu W
    Ann Hematol; 2023 Sep; 102(9):2471-2481. PubMed ID: 37160794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
    Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
    Hong JY; Yoon DH; Suh C; Huh J; Do IG; Sohn I; Jo J; Jung SH; Hong ME; Yoon H; Ko YH; Kim SJ; Kim WS
    Ann Oncol; 2015 Mar; 26(3):548-55. PubMed ID: 25475080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological analysis of neoplastic PD-L1-positive EBV
    Takahara T; Satou A; Ishikawa E; Kohno K; Kato S; Suzuki Y; Takahashi E; Ohashi A; Asano N; Tsuzuki T; Nakamura S
    Virchows Arch; 2021 Mar; 478(3):541-552. PubMed ID: 32803453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].
    Wu WN; Xiang CX; Ma DS; Liu GZ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):506-511. PubMed ID: 35673721
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
    Ishikawa E; Kato S; Shimada K; Tanaka T; Suzuki Y; Satou A; Kohno K; Sakakibara A; Yamamura T; Nakamura M; Miyahara R; Goto H; Nakamura S; Hirooka Y
    Cancer Med; 2018 Dec; 7(12):6051-6063. PubMed ID: 30449068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
    Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
    J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.
    Song CG; Huang JJ; Li YJ; Xia Y; Wang Y; Bi XW; Jiang WQ; Huang HQ; Lin TY; Li ZM
    PLoS One; 2015; 10(7):e0133973. PubMed ID: 26222726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.
    Cassim S; Antel K; Chetty DR; Oosthuizen J; Opie J; Mohamed Z; Verburgh E
    Pathology; 2020 Jun; 52(4):453-459. PubMed ID: 32305135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma.
    Kim JH; Cho H; Sung H; Jung AR; Lee YS; Lee SW; Ryu JS; Chae EJ; Kim KW; Huh J; Park CS; Yoon DH; Suh C
    Sci Rep; 2021 Feb; 11(1):2880. PubMed ID: 33536508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
    Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
    Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
    Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.
    Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
    Am J Hematol; 2018 Jul; 93(7):953-962. PubMed ID: 29984868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
    Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
    Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
    Ziarkiewicz M; Wołosz D; Dzieciątkowski T; Wilczek E; Dwilewicz-Trojaczek J; Jędrzejczak WW; Gierej B; Ziarkiewicz-Wróblewska B
    Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):159-69. PubMed ID: 26084760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.
    Ok CY; Li L; Xu-Monette ZY; Visco C; Tzankov A; Manyam GC; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Chen J; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ai W; Ponzoni M; Ferreri AJ; Farnen JP; Møller MB; Bueso-Ramos CE; Miranda RN; Winter JN; Piris MA; Medeiros LJ; Young KH
    Clin Cancer Res; 2014 May; 20(9):2338-49. PubMed ID: 24583797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.